Award
NIH Reporter #5R01CA284860-03
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC
Recipient
National Cancer Institute (NCI), part of the National Institutes of Health (NIH), US
Award Amount
$649,881.00
Ceiling
$649,881.00
Awarded
August 21, 2025
Identifier
5R01CA284860-03
A research project funded by the National Cancer Institute to evaluate the effects of hemp-derived CBD/THC on various health aspects in cancer patients through a placebo-controlled randomized trial.
Description
This project involves a placebo-controlled randomized trial to study the effects of hemp-derived CBD/THC on cancer patients, focusing on sleep, pain, mood, cognitive functioning, and quality of life.